INTERNATIONAL PATENT: JIANGSU HENGRUI PHARMACEUTICALS CO., LTD., 江苏恒瑞医药股份有限公司, SHANGHAI SHENGDI PHARMACEUTICAL CO., LTD., 上海盛迪医药有限公司 FILES APPLICATION FOR "USE OF ANTI-NECTIN-4 ANTIBODY-DRUG CONJUGATE FOR TREATING TUMOR"

Posted On: 2025-12-15

GENEVA, Dec. 15 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (No. 7 Kunlunshan Road, Economic And Technological Development Zone,Lianyungang, Jiangsu 222047), 江苏恒瑞医药股份有限公司 (中国江苏省连云港市经济技术开发区昆仑山路7号), SHANGHAI SHENGDI PHARMACEUTICAL CO., LTD. (No.1288 Haike Road, Zhangjiang Town,Pudong New Area, Shanghai 201210), 上海盛迪医药有限公司 (中国上海市浦东新区张江镇海科路1288&...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: JIANGSU HENGRUI PHARMACEUTICALS CO., LTD., 江苏恒瑞医药股份有限公司, SHANGHAI SHENGDI PHARMACEUTICAL CO., LTD., 上海盛迪医药有限公司 FILES APPLICATION FOR "USE OF ANTI-NECTIN-4 ANTIBODY-DRUG CONJUGATE FOR TREATING TUMOR"